Skin Grafting Market

Report Overview

The global skin grafting market was pegged at US$ 4.1 billion in 2021 and is expected to witness a CAGR of 6.9 % during the forecast period.

Market Fundamentals 

The skin graft is one of the most indispensable techniques in plastic surgery and dermatology. It is a surgical procedure that involves removing healthy skin from one area of the body and moving/transplanting it to damaged or missing part of the body. Skin grafts are used in a variety of clinical situations, such as treating deep burns, closing large, open wounds, treating pressure injuries or bed sores, defects after oncologic resection, vitiligo, etc. It improves the function and appearance of the damaged area of the body which had undergone the skin grafting procedure.

[56786545]

Market Dynamics

Growing incidences of different conditions like skin cancer, diabetes, necrotizing fasciitis, and burn injuries that require removal or repair of damaged skin are expected to boost the growth of the skin graft market. Furthermore, the rising application of skin grafting in restorative surgeries, technological advancement in skin grafting, and favorable reimbursement policies are also expected to propel the growth of the market. However, complexity in the procedure and cost associated with the process are expected to hinder the growth of the market.

Market Ecosystem

The global skin grafting market has been analyzed from five perspectives: By Graft Type, Product, Application, End User, and Region. 

Skin Grafting Market by Graft Type

[2323232]

Based on graft types, the global skin grafting market has been segmented into autograft, allograft, xenograft, isograft, and prosthetic graft. 

• In autograft the donor skin is taken from a different site on the same individual's body
• In allograft, donor skin is obtained from another person
• In xenograft, the donor and recipient are of different species
• In isograft, the donor and recipient individuals are genetically identical twin
• In prosthetic graft, lost tissue is replaced with synthetic materials such as metal, plastic, or ceramic

The autograft segment holds the highest share in the skin grafting market. In autograft procedure skin is taken from the patients themself, and there is no need for donor graft. Autologous split-thickness skin grafting is the most practiced form of tissue transplantation in plastic surgery at present.

Global Skin Graft Market by Product

Based on product, the global skin grafting market has been segmented into graft mesher, dermatome, wound debridement devices and others. Dermatome dominates the skin grafting market with the highest share. A dermatome is a surgical instrument used to produce thin slices of skin from a donor site and is the main tool for skin graft harvesting. There are various types of dermatomes which are used for skin grafting such as knives, drum, electric and air. Dermatomes are widely used owing to their relatively higher speed, precision, and consistent harvest of large uniform-thickness grafts.

Global Skin Graft Market by Application

Based on application, the global skin grafting market is segmented into burns, surgical wounds, traumatic wounds, chronic wounds, and others (skin disease like necrotizing facilitis/purpura fulminans, etc.). Surgical wounds segment holds the largest share in the skin grafting market. The prominence of the segment can be attributed to rising geriatric population with different health conditions that requires surgical interventions, thereby increasing the number of surgeries performed. Moreover, rising prevalence of skin cancer is also expected to boost the growth of the market.

Global Skin Graft Market by End User

Based on end users, the global skin grafting market has been segmented into hospitals & clinics, research institutes and ambulatory surgical centers. Hospitals & clinics holds the largest share and is expected to dominate skin grafts market during the forecast period. The growth of the segment can be attributed to the high procedure rate in hospital and availability of advanced technology and skilled personnel. Additionally, patient’s preference to visit hospitals for treatment of trauma cases, road accident and burn cases is also expected to propel the growth of the segment.

Skin Graft Systems Market by Region

Based on region, the global skin grafting market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the skin grafting market, followed by Asia Pacific. North America is expected to hold the largest share in the market during forecast period. The growth of the North America segment can be attributed to developed healthcare infrastructure, presence for prominent players, favorable reimbursement policies and high adoption of advanced technology and more effective procedures.

Competitive Landscape

Some of the prominent players operating in the global skin grafting market are 

• Zimmer Biomet
• B. Braun Melsungen AG
• Integra LifeScience
• MIMEDX
• Smith+Nephew
• Nouvag AG
• Exsurco Medical, Inc
• Rudolf Storz GmbH
• De Soutter Medical
• AVITA Medical
• Among others

Strategic Developments

• In Feb 2022, the RECELL System by AVITA Medical, Inc. was approved by Japan Pharmaceutical and Medical Devices Agency (PMDA)This collaboration was made to provide the customer better and efficient services 
• In Jan 2021, The BioAesthetics Corp. received a grant of $250,000 from National Science Foundation. This funding was provided for development of technologically advanced wound-care product that can be used for the treatment of pressure ulcers
• In October 2021, Kerecis, received the US Food and Drug Administration (FDA) marketing authorization for its Omega3 SurgiBind, an implantable fish-skin graft intended for use in plastic and reconstructive surgery
• In June 2021, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated 
• In April 2021, Urgo Group SAS was awarded $27.7 million in financial support from the French government, to help develop artificial skin for treating deep skin wounds and massive burns
• In June 2020, CUTISS, successfully raised €18.72 million in Series B funding to help patients who suffer from large and deep skin defects. This funding is aimed to allow CUTISS to further progress denovoSkin™, the company’s unique personalized skin technology to treat skin defects due to burns

Frequently Asked Questions About This Report